Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 188

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 188
---
                                                                                                               Working capital loans 
                                                     to finance transaction costs in connection with an initial business combination |
|                                                                                                        |     | Reimbursement for any out-of-pocket                                                                                                 
 expenses related to identifying, investigating and completing an initial business combination                                       |     |                                                                                                              Services in connection 
                                                      with identifying, investigating and completing an initial business combination |
|                                                                                                        |     | Finder’s fees, advisory                                                                                                             
 fees, consulting fees or success fees                                                                                               |     |                                                                                                            Any services in order to 
 effectuate the completion of our initial business, which, if made prior to the completion of our initial business combination, will 
                                                                                   be paid from funds held outside the trust account |

Because our initial shareholders acquired
the founder shares at a nominal price, our public shareholders will incur immediate and substantial dilution upon the closing of this
offering, assuming no value is ascribed to the warrants included in the units. Further, the Class A ordinary shares issuable in
connection with the conversion of the founder shares may result in material dilution to our public shareholders due to the anti-dilution
rights of our founder shares that may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion.
If the private placement warrants become exercisable on a cashless basis, or if any working capital loans are converted into warrants
as described herein, the exercise of such warrants or conversion of such loans into warrants may also result in material dilution to
our public shareholders. See the sections entitled “Risk Factors — Risks Relating to our Management Team — The nominal purchase price paid by our initial shareholders for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and our initial shareholders are likely to make a substantial profit on their investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to materially decline”, “Risk Factors — Risks Relating to our Securities — Our warrants may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination” and “Dilution.” Additionally, we will reimburse our sponsor
in an amount equal to $10,000 per month for office space, utilities and secretarial and administrative support made available to us,
as described elsewhere in this prospectus.

The founder shares will automatically convert
into Class A ordinary shares concurrently with or immediately